BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	15,612	18,162	19,234	16,220	15,918	15,187
Market Cap Growth	-9.15%	-5.57%	18.58%	1.90%	4.81%	0.17%
Enterprise Value	15,653	18,176	19,025	16,286	15,928	15,282
PE Ratio	77.57	108.34	135.87	-253.13	18.64	-636.84
PS Ratio	6.32	7.51	9.18	8.79	8.56	8.91
PB Ratio	3.08	3.67	4.18	3.80	3.88	4.86
P/FCF Ratio	81.39	290.28	121.52	77.63	416.58	-211.63
P/OCF Ratio	55.72	114.04	109.34	53.26	186.47	314.68
EV/Sales Ratio	6.33	7.51	9.08	8.82	8.56	8.97
EV/EBITDA Ratio	43.50	58.58	71.12	339.10	186.33	450.13
EV/EBIT Ratio	61.50	88.27	114.92	-271.37	-809.03	-214.18
EV/FCF Ratio	81.60	290.49	120.21	77.94	416.83	-212.94
Debt / Equity Ratio	0.21	0.22	0.24	0.25	0.26	0.27
Debt / EBITDA Ratio	3.02	3.50	4.05	22.47	12.58	24.98
Debt / FCF Ratio	5.67	17.37	6.84	5.16	28.14	-11.82
Quick Ratio	1.55	1.45	2.98	2.54	3.07	1.21
Current Ratio	2.74	2.51	4.67	4.16	4.76	2.08
Asset Turnover	0.37	0.36	0.34	0.31	0.34	0.38
Interest Coverage	14.82	11.88	10.37	-3.91	-0.67	-3.04
Return on Equity (ROE)	4.20%	3.50%	3.10%	-1.50%	23.30%	-0.80%
Return on Assets (ROA)	3.00%	2.50%	2.30%	-1.10%	15.50%	-0.50%
Return on Capital (ROIC)	2.63%	2.33%	2.49%	-1.54%	-0.84%	-2.53%
Earnings Yield	1.32%	0.92%	0.74%	-0.40%	5.37%	-0.16%
FCF Yield	1.23%	0.34%	0.82%	1.29%	0.24%	-0.47%
Buyback Yield / Dilution	-2.52%	-1.39%	-3.34%	4.60%	-7.06%	-1.00%
Total Shareholder Return	-2.52%	-1.39%	-3.34%	4.60%	-7.06%	-1.00%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).